FDA Inspection
Molecular PharmaGroupMolecular PharmaGroup – FDA Inspection, Dec 11, 2023
Record Details
This FDA Inspection record concerns Molecular PharmaGroup, with an inspection on December 11, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 77871794-9244-4db7-ad18-46ed42d4d7ed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224590
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- Drug product labels, fails to include
- All inclusive product report, not submitted
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Molecular PharmaGroup
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 11, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
Other documents for Molecular PharmaGroup
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.